Skip to main content
. Author manuscript; available in PMC: 2017 Dec 1.
Published in final edited form as: J Pharmacokinet Pharmacodyn. 2016 Sep 26;43(6):567–582. doi: 10.1007/s10928-016-9495-8

Figure 8.

Figure 8

Cell viability profiles for GFP-MCF7 cells in co-cultures with increasing percentage of BT474 cells (upper two rows) and SKBR3 cells (lower two rows). Black lines represent control group without ADC treatment and the gray lines represent the group treated with 500 nM T-vc-MMAE ADC.